<VariationArchive VariationID="132818" VariationName="NM_002641.4(PIGA):c.1030_1032del (p.Leu344del)" VariationType="Deletion" Accession="VCV000132818" Version="5" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2017-04-27" MostRecentSubmission="2022-09-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="136567" VariationID="132818">
      <GeneList>
        <Gene Symbol="PIGA" FullName="phosphatidylinositol glycan anchor biosynthesis class A" GeneID="5277" HGNC_ID="HGNC:8957" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="15319451" stop="15335554" display_start="15319451" display_stop="15335554" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="15337572" stop="15353675" display_start="15337572" display_stop="15353675" Strand="-" />
          </Location>
          <OMIM>311770</OMIM>
          <Haploinsufficiency last_evaluated="2024-07-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PIGA">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2024-07-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PIGA">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_002641.4(PIGA):c.1030_1032del (p.Leu344del)</Name>
      <CanonicalSPDI>NC_000023.11:15324820:AAG:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="15324821" stop="15324823" display_start="15324821" display_stop="15324823" variantLength="3" positionVCF="15324820" referenceAlleleVCF="TAAG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="15342943" stop="15342945" display_start="15342943" display_stop="15342945" variantLength="3" positionVCF="15342942" referenceAlleleVCF="TAAG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>L344del</ProteinChange>
      <ProteinChange>L110del</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020473.3" sequenceAccession="NM_020473" sequenceVersion="3" change="c.328_330del">
            <Expression>NM_020473.3:c.328_330del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065206.3" sequenceAccession="NP_065206" sequenceVersion="3" change="p.Leu110del">
            <Expression>NP_065206.3:p.Leu110del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.15342943_15342945del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.15342943_15342945del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.15324821_15324823del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.15324821_15324823del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009786.1" sequenceAccession="NG_009786" sequenceVersion="1" change="g.15716_15718del">
            <Expression>NG_009786.1:g.15716_15718del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002641.4" sequenceAccession="NM_002641" sequenceVersion="4" change="c.1030_1032del" MANESelect="true">
            <Expression>NM_002641.4:c.1030_1032del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002632.1" sequenceAccession="NP_002632" sequenceVersion="1" change="p.Leu344del">
            <Expression>NP_002632.1:p.Leu344del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_033835.1" sequenceAccession="NR_033835" sequenceVersion="1" change="n.772_774del">
            <Expression>NR_033835.1:n.772_774del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_033836.1" sequenceAccession="NR_033836" sequenceVersion="1" change="n.488_490del">
            <Expression>NR_033836.1:n.488_490del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_160" sequenceAccession="LRG_160">
            <Expression>LRG_160:g.15716_15718del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002641.3" sequenceAccession="NM_002641" sequenceVersion="3" change="c.1030_1032delCTT">
            <Expression>NM_002641.3:c.1030_1032delCTT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020473.3" sequenceAccession="NM_020473" sequenceVersion="3" change="c.328_330delCTT">
            <Expression>NM_020473.3:c.328_330delCTT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA156226" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="311770.0016" DB="OMIM" />
        <XRef Type="rs" ID="587777399" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002641.4(PIGA):c.1030_1032del (p.Leu344del) AND not provided" Accession="RCV000478249" Version="9">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-05-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002641.4(PIGA):c.1030_1032del (p.Leu344del) AND Neurodevelopmental disorder with epilepsy and hemochromatosis" Accession="RCV002221150" Version="9">
        <ClassifiedConditionList TraitSetID="74224">
          <ClassifiedCondition DB="MedGen" ID="CN307964">Neurodevelopmental disorder with epilepsy and hemochromatosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2014-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002641.4(PIGA):c.1030_1032del (p.Leu344del) AND Multiple congenital anomalies-hypotonia-seizures syndrome 2" Accession="RCV002281561" Version="8">
        <ClassifiedConditionList TraitSetID="7922">
          <ClassifiedCondition DB="MedGen" ID="C3275508">Multiple congenital anomalies-hypotonia-seizures syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2002-09-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-05-13" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2017-04-27" MostRecentSubmission="2022-09-10">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">24259288</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7922" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="16845" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 4</ElementValue>
                <XRef Type="MIM" ID="300868" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 20</ElementValue>
                <XRef Type="MIM" ID="300868" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Multiple congenital anomalies-hypotonia-seizures syndrome 2</ElementValue>
                <XRef ID="MULTIPLE+CONGENITAL+ANOMALIES-HYPOTONIA-SEIZURES+SYNDROME+2/8915" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010466" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EIEE20</ElementValue>
                <XRef Type="MIM" ID="300868" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GPIBD4</ElementValue>
                <XRef Type="MIM" ID="300868" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">MCAHS2</ElementValue>
                <XRef Type="MIM" ID="300868" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12777" />
                <XRef ID="12777" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="300496" DB="Orphanet" />
              <XRef ID="C3275508" DB="MedGen" />
              <XRef ID="MONDO:0010466" DB="MONDO" />
              <XRef Type="MIM" ID="300868" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="74224" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="62214" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neurodevelopmental disorder with epilepsy and hemochromatosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NEDEPH</ElementValue>
                <XRef Type="MIM" ID="301072" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FCCS</ElementValue>
                <XRef Type="MIM" ID="301072" DB="OMIM" />
              </Symbol>
              <XRef ID="CN307964" DB="MedGen" />
              <XRef Type="MIM" ID="301072" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1101939" SubmissionDate="2019-01-29" DateLastUpdated="2017-04-27" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDX:442455|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000566832" DateUpdated="2017-04-27" DateCreated="2017-04-27" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-05-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1030_1032delCTT pathogenic variant in the PIGA gene has been reported previously in a multi-generationalfamily with three affected males with neurodegeneration, cutaneous abnormalities and systemic iron overload(Swoboda et al., 2014). Analysis of blood cells from an affected individual showed deficient GPI anchor proteins ingranulocytes but not erythrocytes or monocytes, suggesting a cell-type dependent reduction of PIGA activity due tothis variant (Swoboda et al., 2014). The c.1030_1032delCTT variant causes an in-frame deletion of codon Leucine344, denoted p.L344del. The Leucine 344 residue is conserved across species. The c.1030_1032delCTT variant wasnot observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI ExomeSequencing Project, indicating it is not a common benign variant in these populations. We interpretc.1030_1032delCTT as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PIGA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002641.3:c.1030_1032delCTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="279709" SubmissionDate="2022-04-05" DateLastUpdated="2022-04-12" DateCreated="2014-06-09">
        <ClinVarSubmissionID localKey="311770.0016_NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HEMOCHROMATOSIS" title="PIGA, 3-BP DEL, 328CTT_NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HEMOCHROMATOSIS" />
        <ClinVarAccession Accession="SCV000154722" DateUpdated="2022-04-12" DateCreated="2014-06-09" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 affected males from a family with neurodevelopmental disorder with epilepsy and hemochromatosis (NEDEPH; 301072), Swoboda et al. (2014) identified a hemizygous in-frame 3-bp deletion (c.328_330delCTT, NM_020473.3) in the PIGA gene, resulting in the deletion of a conserved residue (leu110del). The mutation, which was found by exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family, and was not present in the 1000 Genomes Project or Exome Variant Server databases. Flow cytometric analysis of the proband's granulocytes showed decreased cell surface levels of some GPI-anchored proteins, although CD59 (107271) expression on red blood cells was normal, suggesting that the mutant protein had some residual activity. In addition to neurologic features, the patients had cutaneous abnormalities and evidence of systemic iron overload.</Attribute>
              <Citation>
                <ID Source="PubMed">24259288</ID>
              </Citation>
              <XRef DB="OMIM" ID="301072" Type="MIM" />
              <XRef DB="OMIM" ID="107271" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PIGA" />
          </GeneList>
          <Name>PIGA, 3-BP DEL, 328CTT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, 328CTT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="311770.0016" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HEMOCHROMATOSIS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5025675" SubmissionDate="2022-09-07" DateLastUpdated="2022-09-10" DateCreated="2022-09-10">
        <ClinVarSubmissionID localKey="NM_002641.3:c.1030_1032delCTT|OMIM:300868" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002570078" DateUpdated="2022-09-10" DateCreated="2022-09-10" Type="SCV" Version="1" SubmitterName="Center of Excellence for Medical Genomics, Chulalongkorn University" OrgID="507386" OrganizationCategory="laboratory" OrgAbbreviation="CEMG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-09-08">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>short-read whole exome sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PIGA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002641.3:c.1030_1032delCTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300868" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12033030</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5025675" TraitType="Disease" MappingType="XRef" MappingValue="300868" MappingRef="OMIM">
        <MedGen CUI="C3275508" Name="Multiple congenital anomalies-hypotonia-seizures syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="279709" TraitType="Disease" MappingType="Name" MappingValue="NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HEMOCHROMATOSIS" MappingRef="Preferred">
        <MedGen CUI="CN307964" Name="Neurodevelopmental disorder with epilepsy and hemochromatosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1101939" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

